Literature DB >> 2847948

1,25(OH)2-vitamin D3 receptors: gene regulation and genetic circuitry.

P P Minghetti1, A W Norman.   

Abstract

Our understanding of how vitamin D mediates biological responses has entered a new era. It is now clear that the bulk of the biological responses supported by vitamin D occur as a consequence of its metabolism to its daughter metabolite 1 alpha,25-dihydroxyvitamin D3 (a steroid hormone). The fact that 1,25(OH)2D3 receptors are ubiquitous in tissue distribution opens the possibility for unforeseen biological functions of the vitamin D endocrine system. For example, 1,25(OH)2D3 serves as an immunoregulatory hormone and a differentiation hormone besides its classical role in mineral homeostasis. The avian 1,25)OH)2D3 receptor has recently been cloned and shown to be a member of the nuclear transacting receptor family that includes estrogen, progesterone, glucocorticoid, thyroxine (T3), aldosterone, and retinoic acid receptors. We have compiled an extensive number of RNA polymerase II-transcribed genes that are regulated by 1,25(OH)2D3. Classification of these genes on functional grounds identifies and formulates the several genetic circuits or biochemical systems in which 1,25(OH)2D3 plays an essential regulatory role. These systems include genes that govern oncogene and lymphokine expression as well as those involved in mineral homeostasis, vitamin D metabolism, and regulation of a set of replication-linked genes (c-myc, c-myb, and histone H4), which are critical for rapid cellular proliferation. An integrated analysis of the combinations of genetic circuits regulated by 1,25(OH)2D3 suggests that they may be collectively tied to a DNA replication-differentiation switch.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2847948     DOI: 10.1096/fasebj.2.15.2847948

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  46 in total

1.  Calbindins decreased after space flight.

Authors:  I N Sergeev; W B Rhoten; M D Carney
Journal:  Endocrine       Date:  1996-12       Impact factor: 3.633

2.  Effects of 1 alpha,25-dihydroxyvitamin D3 and cytokines on the expression of MHC antigens, complement receptors and other antigens on human blood monocytes and U937 cells: role in cell differentiation, activation and phagocytosis.

Authors:  A Spittler; M Willheim; F Leutmezer; R Ohler; W Krugluger; C Reissner; T Lucas; T Brodowicz; E Roth; G Boltz-Nitulescu
Journal:  Immunology       Date:  1997-02       Impact factor: 7.397

Review 3.  The circadian control of skin and cutaneous photodamage.

Authors:  Joshua A Desotelle; Melissa J Wilking; Nihal Ahmad
Journal:  Photochem Photobiol       Date:  2012-02-21       Impact factor: 3.421

4.  1,25-dihydroxyvitamin D3 modulates growth of vascular smooth muscle cells.

Authors:  T Mitsuhashi; R C Morris; H E Ives
Journal:  J Clin Invest       Date:  1991-06       Impact factor: 14.808

5.  Upregulation of 25-hydroxyvitamin D(3)-1(alpha)-hydroxylase by butyrate in Caco-2 cells.

Authors:  Oliver Schröder; Sinan Turak; Carolin Daniel; Tanja Gaschott; Jürgen Stein
Journal:  World J Gastroenterol       Date:  2005-12-07       Impact factor: 5.742

6.  1,25-Dihydroxyvitamin D3 binding sites in the eye and associated tissues of the green lizard Anolis carolinensis.

Authors:  H J Bidmon; W E Stumpf
Journal:  Histochem J       Date:  1995-07

7.  Characterization of the 1,25-dihydroxycholecalciferol-stimulated calcium influx pathway in CaCo-2 cells.

Authors:  X Y Tien; C Katnik; B M Qasawa; M D Sitrin; D J Nelson; T A Brasitus
Journal:  J Membr Biol       Date:  1993-11       Impact factor: 1.843

8.  The effect of 1, 25-dihydroxyvitamin D3 on the growth of soft-tissue sarcoma cells as mediated by the vitamin D receptor.

Authors:  M Shabahang; A E Buffan; J M Nolla; L M Schumaker; R V Brenner; R R Buras; R J Nauta; S R Evans
Journal:  Ann Surg Oncol       Date:  1996-03       Impact factor: 5.344

9.  1 alpha,25-Dihydroxyvitamin D3 inhibits the invasive potential of human breast cancer cells in vitro.

Authors:  C M Hansen; T L Frandsen; N Brünner; L Binderup
Journal:  Clin Exp Metastasis       Date:  1994-05       Impact factor: 5.150

10.  Antiproliferative effects of the biologically active metabolite of vitamin D3 (1,25 [OH]2 D3) on head and neck squamous cell carcinoma cell lines.

Authors:  J Kornfehl; M Formanek; A Temmel; B Knerer; M Willheim
Journal:  Eur Arch Otorhinolaryngol       Date:  1996       Impact factor: 2.503

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.